A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: The Speed of Onset of Therapeutic Assessment Trial (STAT)

Clinical Therapeutics

Volumn 24, Issue 4, 2002, Pages 616-628

  Siami, Paul ^a   Seidman, Larry S ^b   Lama, Daniel ^c  

^a Welborn Clinic   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c San Bernardino Urological Associates   (United States)

Author keywords

Onset of action; Overactive bladder; Perception; Tolterodine extended release; Urinary incontinence

Indexed keywords

TOLTERODINE;

ADULT; AGED; ARTICLE; BLADDER DYSFUNCTION; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; MULTICENTER STUDY; SOMNOLENCE; SUSTAINED RELEASE PREPARATION; TACHYCARDIA; TREATMENT OUTCOME; URGE INCONTINENCE; URINE INCONTINENCE; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0036250346     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)85137-2     Document Type: Article

References (17)

1. Factors involved in the success of antimuscarinic treatment
2. The pharmacology of lower urinary tract smooth muscles and penile erectile tissues
3. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: A double blind placebo controlled study
4. Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: Oxybutynin versus propantheline versus placebo
5. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis
6. Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder
7. Tolterodine, a new antimuscarinic agent: As effective but better tolerated than oxybutynin in patients with an overactive bladder
8. Tolterodine once-daily: Superior efficacy and tolerability in the treatment of the overactive bladder
9. Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivity
10. A comparison of the efficacy response profile of tolterodine and oxybutynin
11. Delay to maximum effect in overactive bladder patients treated with oxybutynin or tolterodine
12. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence
13. Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence
14. Methods used to manage urinary incontinence by older adults in the community
15. Coping strategies and health care-seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder
16. Comparison between urinary diaries completed with and without intensive patient instructions
17. Reproducibility of the seven-day voiding diary in women with stress urinary incontinence